Dynamic Behaviour of Donor Specific Antibodies in the Early Period Following HLA Incompatible Kidney Transplantation
- PMID: 35516975
- PMCID: PMC9062976
- DOI: 10.3389/ti.2022.10128
Dynamic Behaviour of Donor Specific Antibodies in the Early Period Following HLA Incompatible Kidney Transplantation
Abstract
In HLA-incompatible kidney transplantation, monitoring donor-specific antibodies (DSA) plays a crucial role in providing appropriate treatment and increases kidney survival times. This work aimed to determine if early post-transplant DSA dynamics inform graft outcome over and above other predictive factors. Eighty-eight cases were classified by unsupervised machine learning into five distinct DSA response groups: no response, fast modulation, slow modulation, rise to sustained and sustained. Fast modulation dynamics gave an 80% rate for early acute rejection, whereas the sustained group was associated with the lowest rejection rates (19%). In complete contrast, the five-year graft failure was lowest in the modulation groups (4-7%) and highest in the sustained groups (25-31%). Multivariable analysis showed that a higher pre-treatment DSA level, male gender and absence of early acute rejection were strongly associated with a sustained DSA response. The modulation group had excellent five-year outcomes despite higher rates of early rejection episodes. This work further develops an understanding of post-transplant DSA dynamics and their influence on graft survival following HLA-incompatible kidney transplantation.
Keywords: 5 years graft failure; antibody dynamics; clustering; donor specific antibody; dynamic patterns; kidney transplantation.
Copyright © 2022 Phillpott, Daga, Higgins, Lowe, Krishnan, Zehnder, Briggs and Khovanova.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures







Similar articles
-
Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study.Clin Transpl. 2016;32:173-179. Clin Transpl. 2016. PMID: 28564535
-
Acute Rejection, Kidney Allograft Function, and Graft Survival in Patients with Circulating Pre-Transplant IgG Antibodies Directed Against Donor HLA-A, -B, or -C Locus Determined Antigens.Clin Transpl. 2016;32:83-91. Clin Transpl. 2016. PMID: 28564525
-
Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.Nephrol Dial Transplant. 2017 Apr 1;32(4):730-737. doi: 10.1093/ndt/gfw445. Nephrol Dial Transplant. 2017. PMID: 28339671
-
Donor-Specific HLA Antibodies: A Review of Data Published in 2016.Clin Transpl. 2016;32:13-22. Clin Transpl. 2016. PMID: 28564519 Review.
-
The possible critical role of T-cell help in DSA-mediated graft loss.Transpl Int. 2018 Jun;31(6):577-584. doi: 10.1111/tri.13126. Epub 2018 Mar 8. Transpl Int. 2018. PMID: 29405445 Review.
Cited by
-
Impact of HLA evolutionary divergence and donor-recipient molecular mismatches on antibody-mediated rejection of kidney allografts.Nat Commun. 2025 Jul 1;16(1):5692. doi: 10.1038/s41467-025-60485-y. Nat Commun. 2025. PMID: 40592858 Free PMC article.
-
Imlifidase: Is it the Magic Wand in Renal Transplantation?Indian J Nephrol. 2024 Jul-Aug;34(4):291-296. doi: 10.25259/ijn_325_23. Epub 2024 Apr 29. Indian J Nephrol. 2024. PMID: 39156835 Free PMC article. Review.
-
The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice.Transpl Int. 2023 Jul 25;36:11321. doi: 10.3389/ti.2023.11321. eCollection 2023. Transpl Int. 2023. PMID: 37560072 Free PMC article.
-
Early Donor-Specific HLA Antibodies Detected by Screening in the First Month Posttransplant and Kidney Graft Outcomes.Transpl Int. 2025 Aug 6;38:14424. doi: 10.3389/ti.2025.14424. eCollection 2025. Transpl Int. 2025. PMID: 40843100 Free PMC article.
-
Retrospective Study from a Single Center in Romania of 347 Renal Transplant Patients Treated with Tacrolimus, Mycophenolate, and Steroids to Evaluate the Association Between Anti-HLA Antibodies and 5-Year Graft Survival.Ann Transplant. 2022 Aug 12;27:e937267. doi: 10.12659/AOT.937267. Ann Transplant. 2022. PMID: 35957504 Free PMC article.
References
-
- Manook M, Johnson R, Robb M, Burnapp L, Fuggle SV, Mamode N. Changing Patterns of Clinical Decision Making: Are Falling Numbers of Antibody Incompatible Transplants Related to the Increasing success of the UK Living Kidney Sharing Scheme? A National Cohort Study. Transpl Int (2021) 34:153–62. 10.1111/tri.13776 - DOI - PubMed
-
- Schinstock CA, Smith BH, Montgomery RA, Jordan SC, Bentall AJ, Mai M, et al. Managing Highly Sensitized Renal Transplant Candidates in the Era of Kidney Paired Donation and the New Kidney Allocation System: Is There Still a Role for Desensitization? Clin Transpl (2019) 33:e13751. 10.1111/ctr.13751 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials